Charbonneau and S
Charbonneau and S. the HPV L1 VLP vaccine formulated with or without aluminium adjuvant. == Results == Immunization with VLPs formulated with the aluminium adjuvant elicited a significantly stronger immune response with higher peak antibody titers both at four weeks post vaccination (12.7 to 41.9-fold higher) as well as in…